| Absorption |
| Blood-Brain Barrier | BBB+ | 0.9575 |
| Human Intestinal Absorption | HIA+ | 0.9964 |
| Caco-2 Permeability | Caco2+ | 0.6357 |
| P-glycoprotein Substrate | Substrate | 0.7668 |
| P-glycoprotein Inhibitor | Non-inhibitor | 0.7709 |
| Non-inhibitor | 0.7930 |
| Renal Organic Cation Transporter | Non-inhibitor | 0.8094 |
| Distribution |
| Subcellular localization | Mitochondria | 0.8112 |
| Metabolism |
| CYP450 2C9 Substrate | Non-substrate | 0.8477 |
| CYP450 2D6 Substrate | Non-substrate | 0.9066 |
| CYP450 3A4 Substrate | Substrate | 0.7647 |
| CYP450 1A2 Inhibitor | Non-inhibitor | 0.8748 |
| CYP450 2C9 Inhibitor | Non-inhibitor | 0.8936 |
| CYP450 2D6 Inhibitor | Non-inhibitor | 0.9646 |
| CYP450 2C19 Inhibitor | Non-inhibitor | 0.9333 |
| CYP450 3A4 Inhibitor | Non-inhibitor | 0.8312 |
| CYP Inhibitory Promiscuity | Low CYP Inhibitory Promiscuity | 0.9428 |
| Excretion |
| Toxicity |
| Human Ether-a-go-go-Related Gene Inhibition | Weak inhibitor | 0.9250 |
| Non-inhibitor | 0.8035 |
| AMES Toxicity | Non AMES toxic | 0.9233 |
| Carcinogens | Non-carcinogens | 0.9452 |
| Fish Toxicity | High FHMT | 0.9956 |
| Tetrahymena Pyriformis Toxicity | High TPT | 0.9857 |
| Honey Bee Toxicity | High HBT | 0.8247 |
| Biodegradation | Not ready biodegradable | 0.9741 |
| Acute Oral Toxicity | I | 0.5074 |
| Carcinogenicity (Three-class) | Non-required | 0.5235 |